share_log

A Look Ahead: Arrowhead Pharma's Earnings Forecast

A Look Ahead: Arrowhead Pharma's Earnings Forecast

展望一下:Arrowhead Pharma的盈利預測
Benzinga ·  11/25 22:01

Arrowhead Pharma (NASDAQ:ARWR) is set to give its latest quarterly earnings report on Tuesday, 2024-11-26. Here's what investors need to know before the announcement.

Arrowhead Pharma(納斯達克:ARWR)將於2024年11月26日星期二發佈最新季度業績。投資者在公佈之前需要了解的內容。

Analysts estimate that Arrowhead Pharma will report an earnings per share (EPS) of $-1.05.

分析師預計Arrowhead Pharma將報告每股收益(EPS)爲$-1.05。

The market awaits Arrowhead Pharma's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

市場期待Arrowhead Pharma的公告,希望超越預期並提供積極的下一季度指引的消息。

It's important for new investors to understand that guidance can be a significant driver of stock prices.

新投資者需要明白,指引對股價有重要影響。

Performance in Previous Earnings

Performance in Previous Earnings

The company's EPS missed by $0.83 in the last quarter, leading to a 9.44% drop in the share price on the following day.

上一季度公司的每股收益低於0.83美元,導致次日股價下跌了9.44%。

Here's a look at Arrowhead Pharma's past performance and the resulting price change:

讓我們回顧一下Arrowhead Pharma的過去表現以及隨之而來的價格變動:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate -0.55 -0.16 -0.82 -0.60
EPS Actual -1.38 -1.02 -1.24 -1.02
Price Change % -9.0% -11.0% -5.0% -27.0%
季度 2024年第三季度 2024年第二季度 2024年第一季度 Q4 2023
每股收益預估值 -0.55 -0.16 -0.82 -0.60
每股收益實際值 -1.38 -1.02 -1.24 -1.02
價格變更% -9.0% -11.0% -5.0% -27.0%
bigjpg

Arrowhead Pharma Share Price Analysis

Arrowhead Pharma股價分析

Shares of Arrowhead Pharma were trading at $18.54 as of November 22. Over the last 52-week period, shares are down 35.89%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

Arrowhead Pharma的股票價格截至11月22日爲18.54美元。在過去的52週期間,股價下跌了35.89%。考慮到這些回報通常爲負值,長期股東可能會因即將發佈的業績而感到不滿。

To track all earnings releases for Arrowhead Pharma visit their earnings calendar on our site.

要追蹤Arrowhead Pharma所有的業績信息,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文是由Benzinga的自動內容引擎生成,並由編輯審核。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論